The in vivo engraftment potential of GSH-generated PAX7+ myogenic progenitors was also validated in immunodeficient mouse models of DMD (Arpke et al., 2013) and limb girdle muscular dystrophy type 2A (Selvaraj et al., 2019a). This evidence concerns the gene PAX7 and Duchenne muscular dystrophy.